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ABSTRACT The human mas oncogene was originally de-
tected by its ability to transform NIH 3T3 cells. We previously
showed that the protein encoded by this gene is unique among
cellular oncogene products in that it has seven hydrophobic
potential transmembrane domains and shares strong sequence
similarity with a family of hormone-receptor proteins. We have
now cloned the rat homolog of the mas oncogene, determined its
DNA sequence, and examined its expression in various rat tissues.
A comparison of the predicted sequences of the rat and human
mas proteins shows that they are highly conserved, except in their
hydrophilic amino-terminal domains. Our examination of the
expression of mas, determined by RNA-protection studies, indi-
cates that high levels of mas RNA transcripts are present in the
hippocampus and cerebral cortex of the brain, but not in other
neural regions or in other tissues. This pattern of expression and
the simiarit of mas protein to known receptor proteins suggest
that mas encodes a receptor that is involved in the normal
neurophysiology and/or development of specific neural tissues.
The human mas oncogene was originally detected by its
ability to render NIH 3T3 cells tumorigenic in nude mice (1).
This gene encodes a protein that is unique among cellular
oncogene products both in its structure and in its transform-
ing properties (1, 2). The mas protein shares a close structural
similarity with a group of transmitter and hormone receptors
that includes the visual opsins (3), the a2-, I31-, and 1p2-ad-
renergic receptors (4-7), the Ml and M2 muscarinic acetyl-
choline receptors (8, 9), and the substance K receptor (10).
The mas protein and these receptors exhibit similar hydro-
phobicity patterns that predict seven distinct transmembrane
domains. Furthermore, these sequences all share limited
amino acid sequence homology, which suggests that they
may have been derived from a common ancestral gene (3, 8-
12). In addition to their structural similarity, several of these
receptors have been shown to be linked to second-messenger
pathways through the activation of guanine nucleotide-
binding regulatory proteins (G proteins). Based on these
similarities, the mas protein may also be a receptor that
activates a G protein. To provide additional information on
the normal role of the mas gene, we have studied its pattern
of expression in rat tissues. In this paper, we describe t' s
cloning and DNA sequencel of the rat homolog of the mus
oncogene and demonstrate its high-level expression in the
hippocampus and cerebral cortex but not in other regions of
the rat brain.
MATERIALS AND METHODS
DNA Sequencing. DNA sequences were determined in both
orientations by the dideoxynucleotide chain-terminating
method (13).
RNA Purification. Tissues were dissected from Sprague-
Dawley rats (100-150). Brains were dissected according to
the procedure of Glowinski and Iversen (14). RNA was
purified from rat tissues by published procedures (15, 16).
Frozen tissue was solubilized in 7.6 M guanidine hydrochlo-
ride (Fluka)/50 mM potassium acetate, pH 5.5, with a
Polytron (Brinkmann). Ethanol (0.6 volume) was added and
RNA was selectively precipitated at - 20'C for several hours.
After centrifugation in an International Equipment DPR-6000
centrifuge at 3000 x g for 15 min, the RNA pellet was
dissolved in the same guanidine hydrochloride buffer by brief
heating at 60'C, extracted with phenol/chloroform (1:1,
vol/vol) several times, and precipitated as described above.
The RNA pellet was dissolved in the same buffer, precip-
itated a third time, and dissolved in 10 mM Tris HCl buffer
(pH 7.2).
RNA Probes and Hybridization. SP6 RNA polymerase
(Boehringer Mannheim) was used as described (17, 18) to
make 32P-labeled RNA transcripts from a clone, pSPRS2,
which contains a 406-base-pairfragment ofthe rat mas coding
region cloned in the antisense orientation relative to the SP6
promoter. Prior to in vitro transcription, the DNA template
was linearized with Pvu II restriction endonuclease, which
cuts at a single site about 600 base pai , downstream from the
SP6 promoter. Thus, transcription by SP6 polymerase gen-
erated 600-base-long RNA transcripts. This labeled RNA
probe was hybridized to 25 ug of total RNA from rat tissue
in 30 1.l of 80% (vol/vol) formamide/400 mM NaCI/1 mM
EDTA/40 mM Pipes, pH 6.4, at 500C for 12-16 hr. The RNA
was then treated with RNases T1 and T2 (Bethesda Research
Laboratories) in 300 gl of 50 mM sodium acetate/2 mM
EDTA/100 mM sodium chloride, pH 5.0, for 60 min at 30'C
to digest unhybridized RNA. Samples were then extracted
with phenol/chloroform (1:1) three times, precipitated with 8
pug oftRNA, and electrophoresed in a 4% polyacrylamide gel
containing 8M urea. The gel was dried and exposed to Kodak
XAR-5 film.
RESULTS
Cloning and Sequence of the Rat mas Gene. We cloned the
rat homolog ofthe mas oncogene primarily to use it as a probe
for studying mas expression in rat tissues. Blot analysis of
EcoRI-cleaved rat genomic DNA showed that a single 5-
kilobase fragment hybridized to a nick-translated, 32P-labeled
human mas probe (data not shown). To clone this DNA
sequence, EcoRI-cleaved rat DNA was fractionated by
electrophoresis in a 1% agarose gel and theDNA was purified
from the region ofthe gel that contained the hybridizing DNA
Abbreviation: G protein, guanine nucleotide-binding regulatory pro-
tein.
tThe sequence reported in this paper is being deposited in the
EMBL/GenBank data base (IntelliGenetics, Mountain View, CA,
and Eur. Mol. Biol. Lab., Heidelberg) (accession no. J03823).
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fragment. A library was constructed from this DNA in the
AgtlO vector (19), and clones that hybridized to a human mas
probe were isolated from this library. One of these clones,
p$M1, was sequenced and found to contain an open reading
frame encoding a protein that is highly homologous to the
human mas protein. Like the human mas gene, the rat ho-
molog appears not to have introns in its coding region. This
is a property shared by several other genes encoding mem-
bers of this family of receptors.
Fig. 1 shows a comparison of the DNA and predicted
amino acid sequences of the rat and human mas gene coding
regions. The rat and human protein sequences are almost
identical except in their amino- and carboxyl-terminal do-
mains. The DNA sequences are 85% identical in the coding
regions, and strong homology extends 36 base pairs upstream
and $0 base pairs downstream from the coding regions. The
rat sequence codes for a protein with 324 amino acid residues,
whereas the human mas protein has 325 amino acid residues.
This difference in length is due to the presence of one
additional amino acid in the amino-terminal domain of the
human mas protein that is absent in the rat mas protein.
The rat and human proteins share 90% amino acid identity
overall, with most of the differences occurring in the amino-
terminal hydrophilic domains, which are only 52% identical.
The sequence homology that exists between the amino-
terminal domains reflects, in part, the conservation of three
potential N-glycosylation sites.
The structural similarity between the rat and human mas
proteins suggests that their interactions with ligands and
effector molecules have also been conserved. The hydropho-
bic domains of receptors that are related to the mas protein
are thought to be involved in ligand binding (20-22). In
rhodopsin it has been shown that the photoactive molecule,
retinal, binds within the hydrophobic core of the protein (22).
If the ligand for the mas protein also binds within the
hydrophobic core, then the high conservation of the hydro-
phobic domains of the human and rat mas proteins argues
that they interact with similar or identical ligands.
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FIG. 1. Comparison of the DNA and predicted amino acid sequences of the rat and human mas gene coding regions. Amino acid residues
that are identical in corresponding positions of the two proteins are shaded.
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The rat and human mas proteins are functionally similar in
their ability to transform NIH 3T3 cells. Clones containing
the Moloney murine leukemia virus promoter linked to the
coding region of either the rat or the human gene are capable
of inducing foci at similar frequencies (data not shown). Cells
transformed by these constructs have a normal morphology
but are very tumorigenic in nude mice (2). Although these
data suggest that the particular sequence differences in the
amino- and carboxyl-terminal domains do not grossly alter
the function ofmas protein, they do not rule out the possible
importance ofthese domains in the normal physiology ofmas
protein.
Detection of mas RNA Transcripts. To assay mas RNA
levels in rat tissues, we used a sensitive RNARNA hybrid-
ization procedure that can detect less than 1 copy of mRNA
per cell (17, 18). High-specific-activity antisense transcripts
were made from a short region ofthe rat mas coding sequence
by using SP6 RNA polymerase. This 32P-labeled RNA probe
was then hybridized to total RNA from rat tissue in solution.
The unhybridized single-stranded RNA was digested with
RNases and the protected double-stranded RNA was re-
solved in a polyacrylamide gel. Fig. 2 shows the results of a
screen for mas RNA transcripts in different rat tissues by this
method. This figure shows that mas is expressed in rat brain
but not at detectable levels in other tissues including pan-
creas, small intestine, heart, spleen, kidney, skeletal muscle,
skin, and liver.
To examine the distribution ofmas expression in the brain,
we performed a similar screen with RNA from different re-
gions of the rat brain. Fig. 3 shows that mas RNA transcripts
are present at a high level in the hippocampus and at
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FIG. 2. Expression ofmas RNA in rat tissues. RNA was purified
and analyzed for mas RNA transcripts by RNase protection. Open
triangle indicates the position of migration in the gel of the full-length
600-base RNA probe. The strong signals, indicated by the solid
triangle, represent the 406-base protected region of the RNA probe
that hybridized to rat mas RNA transcripts. The first lane shows the
result of using tRNA in the hybridization as a negative control. The
second lane shows results for RNA from 15C1, a transfected NIH
3T3 (murine) cell line that expresses the rat mas gene. The other lanes
show results for RNA purified from various rat tissues. Of these
tissues, only brain shows a signal. Although faint signals are some-
times seen with RNA from the other tissues, we have shown in
separate experiments that they are totally eliminated by treatment of
the RNA samples, prior to hybridization, with RNase-free DNase I
(Worthington) followed by precipitation in 4 M LiCl to remove
residual DNA.
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FIG. 3. Expression of mas RNA in rat brain regions. RNA was
purified and analyzed for mas RNA transcripts by kNase protection.
Triangles indicate the positions of migration of the full-length RNA
probe (open triangle) and the protected probe fragment (solid
triangle), as in Fig. 2. The first lane represents results for RNA from
15C1 (see Fig. 2 legend). The other lanes show results for RNA from
total rat brain and vanious brain regions.
approximately one-third that level in the cerebral cortex, but
not at appreciable levels in hypothalamus, striatum, medulla
oblongata, cerebellum, or midbrain. By comparing levels of
mas RNA transcripts in the hippocampus with levels in a
transfected cell line, we estimated that mas transcripts
represent roughly 0.005% of hiRNA in the hippocampus.
DISCUSSION
The expression of mas in the hippocampus and cerebral
cortex of the brain suggests that the mas-encoded protein
may be a neurotransmitter receptor that is specifically local-
ized in these neural regions. The idea that some oncogenes
may encode neurotransmitter receptors is supported by
observations that certain monoamines and neuropeptides,
such as serotonin, substance P, and substance K, are mito-
genic in culture (23, 24). The binding sites of most neuro-
transmitters have broad distributions that differ from that of
mas RNA transcripts. Nevertheless, ligands that bind to
certain pharmacologically distinct receptors, such as the
phencyclidine receptor (25, 26) and the N-methyl-D-aspartate
and quisqualate receptors (27-29), have high densities of
binding sites in regions of the hippocampus and cerebral cor-
tex. It is conceivable that the mas gene encodes one of these
known receptors.
A number of neurotransmitter receptors related to mas
protein are thought to be coupled to G proteins. G proteins
function as intermediaries in transmembrane signaling path-
ways to modulate a variety of intracellular responses. Ex-
amples of G-protein modulation of biochemical pathways
include the stimulation and inhibition of adenylate cyclase
(30, 31), stimulation of phosphatidylinositol metabolism (32,
33), regulation of K+ and Ca2" channel activities (34), and
stimulation of retinal cGMP phosphodiesterase activity (35).
G proteins may be involved in transducing signals from a
number of hormones and neurotransmitters to effect other
cellular responses. From the similarity of mas protein to a
Neurobiology: Young et al.
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number of receptors that are coupled to G proteins, we
suspect that mas function is also mediated by a G protein.
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